KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) EPS (Basic) Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 77.05%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 320.46%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 44.22%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -52.54%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -14.12%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 26.25%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -21.17%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 6.65%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 320.46%
Dec 28, 2025 16.23%
Sep 28, 2025 7.97%
Jun 29, 2025 7.92%
Mar 30, 2025 37.97%
Sep 29, 2024 -6.95%
Jun 30, 2024 -6.43%
Mar 31, 2024 -16.87%
Dec 31, 2023 36.54%
Oct 1, 2023 96.99%
Jul 2, 2023 12.79%
Apr 2, 2023 -26.28%
Jan 1, 2023 -3.88%
Oct 2, 2022 36.39%
Jul 3, 2022 -4.63%
Apr 3, 2022 7.26%
Oct 3, 2021 -1.85%
Jul 4, 2021 17.42%
Apr 4, 2021 12.97%
Jan 3, 2021 29.37%
Sep 27, 2020 -1.20%
Jun 28, 2020 -0.95%
Mar 29, 2020 10.51%
Dec 29, 2019 2.54%
Sep 29, 2019 -24.55%
Jun 30, 2019 13.06%
Mar 31, 2019 -4.52%
Dec 30, 2018 -0.58%
Sep 30, 2018 6.70%
Jul 1, 2018 -3.39%
Apr 1, 2018 1.69%
Dec 31, 2017 -85.99%
Oct 1, 2017 -6.08%
Jul 2, 2017 -2.46%
Apr 2, 2017 -0.80%
Jan 1, 2017 4.10%
Oct 2, 2016 13.75%
Jul 3, 2016 2.39%
Apr 3, 2016 9.03%
Jan 3, 2016 7.64%
Sep 27, 2015 3.86%
Jun 28, 2015 47.30%
Mar 29, 2015 2.72%
Dec 28, 2014 124.07%
Sep 28, 2014 13.04%
Jun 29, 2014 14.85%
Mar 30, 2014 9.56%
Dec 29, 2013 20.75%
Sep 29, 2013 -5.09%
Jun 30, 2013 2.85%
Mar 31, 2013 -8.65%
Dec 30, 2012 5.15%
Sep 30, 2012 -3.72%
Jul 1, 2012 -23.96%
Apr 1, 2012 4.03%